Search Results
25 results found-
OFR 1 Chair and CEO message 2 8 Environment 46 2 Our Company 8 9 Social 53 3 CSL's Performance and Strategy 20 OFR 10 CSL's Governance 60 4 CSL's Material Risks 26 11 Share Information 70 5 CSL's Future Prospects 28 12 Key Performance Data Summary 73 6 Powered by Innovation 32 13 Medical Glossary 74 7 CSL's People 40 OFR 14 Financial Performance 75
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
This was added as a gateway condition of the LTI target to ensure the ROIC is delivering an appropriate return each financial year as well as over the seven year rolling 0% 20% 40% 60% 80% 100% average period and aligns with shareholder outcomes.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2020-full.pdf -
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe.
https://www.csl.com/we-are-csl/worldwide-locations -
For our executive KMP in 2019, the Board has approved an average 4% increase in Fixed Reward, no increase in STI and an average 30% increase 0% 20% 40% 60% 80% 100% in LTI targets to recognise that our executive KMP LTI component is significantly below global market comparators.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
68 CSL Limited Annual Report 2017 200 60% 35% 35% 35% 160 43% 43% 43% 43% 43% 60% 120 43% 43% 43% 43% 43% 80 35% 35% 35% 40 120% 70% 85% 70% 85% 85% 70% 85% 85% 0 L Reed L Reed G Boss G Boss G Naylor G Naylor R Repella R Repella D Lamont D Lamont P Perreault P Perreault V Romberg V Romberg K Etchberger K Etchberger A Cuthbertson A Cuthbertson
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
The ROIC measure as the hurdle for our LTI Plan, has been chosen because it is a business critical (high ROIC equals high performance), single (preferred over two 0% 20% 40% 60% 80% 100% measures), and is an absolute return measure (preferred over relative), which is easily understood by shareholders and ● 2019 Total Fixed Reward management alike.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf -
Ready for a challenge? CSL's Summer Internship Program offers roles in Engineering, Manufacturing, Research & Development, Business Operations, and more
https://www.csl.com/careers/early-careers-at-csl/internships/internships-in-the-us -
At-home subcutaneous therapy advances treatment options for patients and marks a milestone in 40 years of delivering on CSL's promise to the HAE patient Community
https://newsroom.csl.com/2022-09-26-CSL-Receives-Manufacturing-and-Marketing-Authorization-in-Japan-for-Berinert-R-S-C-Injection-2000,-as-a-Medicine-for-prevention-of-Acute-Hereditary-Angioedema-HAE-attacks -
Dowling manages logistics, which means getting products where they are needed. He holds himself accountable for environmental impacts and says going green can be as complex as fuel alternatives or as simple as lacing up your boots and planting trees.
https://www.csl.com/we-are-csl/vita-original-stories/2024/green-collar-jobs-of-csl-kieran-dowling -
Additionally, less than half of patients surveyed said they are very/somewhat knowledgeable about how different CIDP treatment options work (40%) or about how different CIDP treatment options are administered (45%). "
https://newsroom.csl.com/2024-01-16-Harris-Poll-Survey-Finds-People-Receiving-Treatment-for-CIDP-Are-Interested-in-Exploring-More-Convenient-Treatment-Options